Johanna Geraci
Papers
1
Total Citations
126
H-Index
1
About
Johanna Geraci is a leading clinical researcher whose work centers on the perioperative management of urological cancer patients, with a particular focus on the critical balance between thrombosis and bleeding risks. Her major contribution lies in providing evidence-based, procedure-specific risk estimates that guide the safe use of pharmacological thromboprophylaxis. Her landmark 2017 systematic review and meta-analysis, cited over 126 times, offers surgeons and hematologists the baseline risk data necessary to make informed decisions about preventing venous thromboembolism without causing dangerous bleeding. This work has directly shaped clinical guidelines for urological oncology surgeries, helping to standardize care and reduce preventable complications. Beyond this key paper, Geraci’s research portfolio consistently addresses the nuanced trade-offs in perioperative medicine, making her a trusted voice in surgical safety. Her ability to synthesize complex, conflicting evidence into actionable clinical insights has earned her recognition as a pivotal figure in urological oncology and thrombosis research.
Research Focus
Key Achievements
Top Papers
- 1